Signing hundreds of hospitals in 1 year: How do domestic IVD companies counterattack?

Liu Juan (pseudonym) is a physician in a township hospital. At 8:15, she received a patient with pain in the liver area. The two ribs were full, and the complexion was yellow with fever. Liu Juan suspected that the cause was abnormal in liver function, so he gave a test sheet for the patient.

This is the first test sheet issued since the hospital's laboratory was upgraded. Liu Juan’s hospital is located in Xiaoxiang Town in the southwest mountainous area. Although the hospital has its own laboratory, but the narrow and dark inspection room, patchwork several instruments, the inconvenience they have been very clear. Except for blood routines, there is no way to detect other items. A slightly more serious disease can only allow patients to go to a larger hospital.

At the end of last year, an inspection equipment company was tendered to re-plan the hospital laboratory. I thought it was the same as before, and it didn't hurt to change one or two instruments. However, Liu Juan did not expect that the inspection room had undergone major changes. In addition to the overall upgrade of the equipment, the laboratory was more standardized, and the overall image and working environment were completely new. For a grassroots doctor like her, it is definitely a lot easier. Of course, the bigger beneficiary is the patient.

Kubel is a national high-tech enterprise in vitro diagnosis in Shenzhen. The company is positioned as a standardized inspection service provider for grassroots hospitals, providing one-stop inspection and construction services for primary hospitals. After 6 years of development, the company has provided self-owned brands of biochemical analyzers, blood analyzers and other inspection equipment for more than 3,000 hospitals at home and abroad. Since the end of 2015, more than 100 grassroots hospitals have been established in more than 20 provinces across the country to establish standardized laboratory departments.

Start-up: IVD may be an opportunity

In 2010, the 21st Winter Olympics is taking place in Vancouver. Zhang Zhiqiang and a few friends gathered in the famous Science and Technology Park in Shenzhen Science and Technology Park. They discussed the performance of the Chinese players in this sports meeting, and even had nothing to do with the Winter Olympics.

Several of my friends were the backbone of several medical device listed companies in Shenzhen. They wanted to find an investment when they started their own business. At this time, Zhang Zhiqiang, after the financial crisis in 2008, is rethinking the future. It is just that the Shenzhen Municipal Government encourages private enterprises to be independent brands in “biomedical, internet, new energy”. Under such a call, he is also eager to try, and hopes to have a chance to establish a brand in the three fields.

1年签约上百家医院:国产IVD企业是如何逆袭的?

Isoprene Gasket

Our medicinal synthetic polyisoprene gasket for injection does not contain any substances that can easily produce pyrogen. We now use a unique technique to add cytotoxicity to the routine test of butyl rubber stoppers such as pyrogen, hemolysis, acute systemic toxicity test and so on. Systemic injection test and intradermal stimulation test have been used abroad for many years.Our good puncture resistance ensures the minimum rate of chip drop during the puncture process and our good self-sealing performance can guarantee no leakage during using process in hospital.Also,good retention of puncture device ensures that there is no needle slider and needle drop in the process of hospital use.

Isoprene Gasket, Medical Synthetic Isoprene Gasket, Pharmaceutical Polyisoprene Disc, Pharmaceutical Synthetic Disc, Gasket for syringe, syringe piston, syringe rubber

SUZHOU CRH PHARMACEUTICAL TECHNOLOGY CO.,LTD , https://www.crh-health.com